Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

Front Pharmacol. 2023 May 12:14:1199951. doi: 10.3389/fphar.2023.1199951. eCollection 2023.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.791376.].

Keywords: Nrf2; chondrocytes; deferoxamine; ferroptosis; osteoarthritis.

Publication types

  • Published Erratum